The global opioid market (オピオイド市場) is expected to reach a value of US$ 45,645.8 million by 2024, with projections suggesting a steady growth rate of 3.4% CAGR through 2034. This anticipated expansion is set to propel the market to an impressive size of US$ 63,472.6 million by 2034.
The global opioid market has been a subject of significant interest and concern due to its impact on public health. Opioids are a class of drugs that include both prescription pain relievers, such as oxycodone, hydrocodone, and morphine, as well as the illegal drug heroin. These drugs are highly effective in managing pain but also carry a risk of addiction and overdose.
Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9640
Market Dynamics:
The opioid market is driven by several factors, including the growing prevalence of chronic pain conditions, an aging population, and the increasing number of surgeries and traumatic injuries requiring pain management. Additionally, the rise in the prescription of opioids for pain relief has contributed to the market’s growth. However, the market is also facing challenges, such as the opioid epidemic, which has led to increased scrutiny and regulations around opioid prescribing and use.
Market Future Outlook:
The future outlook for the opioid market is mixed. On one hand, the market is expected to continue growing, driven by the factors mentioned above. However, there are also concerns about the impact of the opioid epidemic on the market. As a result, there is a growing focus on developing alternative pain management strategies, such as non-opioid medications, physical therapy, and behavioral interventions. These developments could potentially impact the growth trajectory of the opioid market (marché des opioïdes) in the coming years.
Market Insights:
One key insight into the opioid market is the need for a balanced approach to pain management. While opioids can be highly effective in managing pain, they also carry risks that need to be carefully managed. This includes the risk of addiction, overdose, and other adverse effects. As a result, there is a growing emphasis on using opioids judiciously and in combination with other pain management strategies to minimize these risks.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9640
Key Players:
- Aurobindo Pharma Limited
- Assertio Therapeutics Inc.
- AbbVie Inc.
- Actavis Plc
- Amneal Pharmaceuticals LLC,
- Boehringer Ingelheim International GmbH
- Cadila Healthcare Limited
- Fresenius Kabi
- Mallinckrodt Pharmaceuticals
- Endo International plc
Competitive Landscape:
The opioid industry is marked by significant consolidation among major players, who are heavily focused on research and development, particularly for pain management drugs. They are also exploring the potential of opioids in treating conditions like cough and diarrhea. These companies are actively expanding their global presence through new product releases, mergers, and stronger distribution channels to reach broader markets.
Aurobindo Pharma Limited manufactures and supplies generic opioids, contributing to the availability of opioid medications in various formulations. Assertio Therapeutics Inc. specializes in developing and commercializing pain management medications, including certain opioid formulations, with a specific emphasis on abuse-deterrent formulations. AbbVie Inc. is involved in pain management and includes opioid-based products in its portfolio, often in combination formulations for specific medical needs.
Opioid Market (오피오이드 시장) — Key Segments
- By Product Type:
- Morphine
- Codeine
- Fentanyl
- Meperidine
- Methadone
- By Application:
- Cough Suppression
- Analgesia
- Diarrhea Suppression
- By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Store
- Clinics
- Others
- By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
Explore More Related Studies Published by Fact.MR Research:
Stroke Rehabilitation Market (뇌졸중 재활 시장): https://www.factmr.com/report/stroke-rehabilitation-market
Neonatal Infant Care Market (新生児ケア市場): https://www.factmr.com/report/neonatal-infant-care-market
Tissue Processing System Market (Marché des systèmes de traitement des tissus): https://www.factmr.com/report/tissue-processing-system-market
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251–1583, +353–1–4434–232 (D)
Sales Team: sales@factmr.com
